Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Finasteride improves hair loss in women with hyperandrogenism.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Some women with common hair loss may develop permanent hair loss.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The hair follicle is a great model for research to improve hair growth treatments.

Mothers and newborns with dental fillings had higher mercury in their hair, but getting fillings during pregnancy didn't raise mercury levels further.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

A hair wrapped tightly around an infant's toe caused severe damage, requiring early removal and possibly surgery to prevent worse outcomes like amputation.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Mouse amnion can turn into skin and hair follicles with help from certain cells and factors.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Nd:YAG laser can reduce hair with multiple treatments, but permanent removal isn't guaranteed.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Successful hair transplant surgery depends on careful patient selection, proper surgical plan and technique, and attentive aftercare.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Detailed patient history and physical exams are crucial for diagnosing hair loss.